Lv11
10 积分 2024-11-03 加入
Update on PI-RADS Version 2.1 Diagnostic Performance Benchmarks for Prostate MRI: Systematic Review and Meta-Analysis
6小时前
待确认
Gleason Score 3 + 4 (Grade Group 2) Prostate Cancer on Biopsy and Postoperative Pathological Upgrading: A Systematic Review and Meta-Analysis
2个月前
已完结
The additional value of 68Ga‐PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsy
3个月前
已完结
Utility of PSMA-PET derived volumetric parameters in initial risk stratification and prediction of prostate cancer metastasis – a head-to-head comparison of the radiotracers 18F-PSMA-1007 and 68Ga-PSMA-11
3个月前
已完结
Localization of PSMA-avid lesions on PSMA PET-CT on prostate MRI in patients with PI-RADS 3
3个月前
已完结
Discordance between prostate MRI and PSMA-PET/CT: the next big challenge for primary prostate tumor assessment?
3个月前
已完结
Key learning on the promise and limitations of MRI in prostate cancer screening
4个月前
已完结
Clinical and Imaging Predictors of False-Positive and False-Negative Results in Prostate Multiparametric MRI Using PI-RADS Version 2
4个月前
已完结
PSMA PET/CT and PET/MRI in primary staging of prostate cancer and its effect on patient management
4个月前
已完结
Explainable and visualizable machine learning models to predict biochemical recurrence of prostate cancer
6个月前
已完结
皖公网安备34019202002308
